Trademarkia Logo

Canada

C$
MYOHALYX
REGISTERED

on 16 Nov 2022

Last Applicant/ Owned by

ASTELLAS GENE THERAPIES INC.

480 Forbes Blvd.South San Francisco CA 94080

US

Serial Number

2042901 filed on 18th Jun 2020

Registration Number

TMA1151645 registered on 16th Nov 2022

Registration expiry Date

18th Jun 2030

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

MYOHALYX

Trademark usage description

pharmaceutical preparations and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders, namely, x-linked myot Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders, namely, X-Linked Myotubular Myopathy, Pompe Disease, Duchenne Muscular Dystrophy, and Myotonic Dystrophy; therapeutic pharmaceuticals and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders, namely, X-Linked Myotubular Myopathy, Pompe Disease, Duchenne Muscular Dystrophy, and Myotonic Dystrophy.


Classification kind code

11

Mark Details


Serial Number

2042901

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 29th Nov 2021
Search Recorded
Submitted for opposition 20
on 29th Nov 2021
Examiner's First Report
Submitted for opposition 223
on 29th Nov 2021
Total Provisional Refusal
Submitted for opposition 256
on 31st May 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 10th Nov 2020
Agent Changed
Submitted for opposition 257
on 30th Jul 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 29th Jul 2020
Formalized
Submitted for opposition 1
on 29th Jul 2020
Created
Submitted for opposition 228
on 18th Jun 2020
International Registration
Submitted for opposition 30
on 18th Jun 2020
Filed